Literature DB >> 18471904

Altered vesicular dopamine storage in Parkinson's disease: a premature demise.

W Michael Caudle1, Rebecca E Colebrooke, Piers C Emson, Gary W Miller.   

Abstract

Dopamine is a potentially toxic neurotransmitter that has long been speculated to contribute to the pathogenesis of Parkinson's disease (PD). Recent work has demonstrated the importance of proper storage of dopamine in vesicles to maintain dopamine homeostasis, thus protecting neurons from the detrimental effects of dopamine accumulation and breakdown in the cytosol. These studies suggest that factors which affect dopamine storage might increase the susceptibility of dopamine neurons to further environmental or genetic insults, exacerbating the neuronal degeneration that characterizes PD. This review seeks to revisit the pathogenicity of cytosolic dopamine and further address the critical role of neurotransmitter storage in dopamine-mediated neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18471904     DOI: 10.1016/j.tins.2008.02.010

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  37 in total

1.  The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons.

Authors:  Hakeem O Lawal; Hui-Yun Chang; Ashley N Terrell; Elizabeth S Brooks; Dianne Pulido; Anne F Simon; David E Krantz
Journal:  Neurobiol Dis       Date:  2010-05-26       Impact factor: 5.996

Review 2.  Industrial toxicants and Parkinson's disease.

Authors:  W Michael Caudle; Thomas S Guillot; Carlos R Lazo; Gary W Miller
Journal:  Neurotoxicology       Date:  2012-01-30       Impact factor: 4.294

3.  Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus.

Authors:  Tonya N Taylor; Shawn P Alter; Minzheng Wang; David S Goldstein; Gary W Miller
Journal:  Neuropharmacology       Date:  2013-09-08       Impact factor: 5.250

Review 4.  Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives.

Authors:  Khosro Jamebozorgi; Eskandar Taghizadeh; Daryoush Rostami; Hosein Pormasoumi; George E Barreto; Seyed Mohammad Gheibi Hayat; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-11-05       Impact factor: 5.590

Review 5.  The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease.

Authors:  Lena F Burbulla; Dimitri Krainc
Journal:  Neurobiol Dis       Date:  2019-07-25       Impact factor: 5.996

Review 6.  The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration.

Authors:  Danielle E Mor; Malcolm J Daniels; Harry Ischiropoulos
Journal:  Mov Disord       Date:  2019-01-11       Impact factor: 10.338

Review 7.  Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Authors:  Kelly M Lohr; Shababa T Masoud; Ali Salahpour; Gary W Miller
Journal:  Eur J Neurosci       Date:  2016-09-02       Impact factor: 3.386

8.  A biochemical and functional protein complex involving dopamine synthesis and transport into synaptic vesicles.

Authors:  Etienne A Cartier; Leonardo A Parra; Tracy B Baust; Marisol Quiroz; Gloria Salazar; Victor Faundez; Loreto Egaña; Gonzalo E Torres
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

9.  The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease.

Authors:  Teresa G Hastings
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

10.  Alpha-synuclein disrupted dopamine homeostasis leads to dopaminergic neuron degeneration in Caenorhabditis elegans.

Authors:  Pengxiu Cao; Yiyuan Yuan; Elizabeth A Pehek; Alex R Moise; Ying Huang; Krzysztof Palczewski; Zhaoyang Feng
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.